Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Wong: Some ethical considerations for the “off-label” use of drugs such as Avastin. (0.08 sec) 

Some ethical considerations for the “off-label” use of drugs such as Avastin

- nih.gov
D Wong, G Kyle - British Journal of Ophthalmology, 2006 - bjo.bmj.com
Off-label use of drugs is not illegal. Physicians and surgeons are allowed to do
this. It is not uncommon. In a paediatric hospital ward setting, almost half the
prescriptions are unlicensed or are off label. 1 Intravitreal ...
Cited by 8 - Related articles - BL Direct - All 5 versions

[CITATION] Intravitreal injection: balancing the risks


NV Chong, T Adewoyin - Eye, 2007 - nature.com
Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ...
Cited by 2 - Related articles - BL Direct - All 4 versions

Bevacizumab: a new way of doing business?


C Canning, A Lotery - Eye, 2006 - nature.com
This review highlights the history of the development of treatments for
choroidal neovascularization (wct AMD). It examines how drug therapies have
evolved for the management of age-related macular degeneration (AMD) and ...
Cited by 6 - Related articles - BL Direct - All 7 versions

Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration

- prsjournal.com
RM Klein, RB Klein - Retina, 2007 - journals.lww.com
There is controversy over the use of ranibizumab (Lucentis; Genentech, Inc.,
South San Francisco, CA) and bevacizumab (Avastin; Genentech, Inc.) for treating
wet age-related macular degeneration (AMD), the leading cause of blindness ...
Cited by 7 - Related articles - BL Direct - All 3 versions

The international intravitreal bevacizumab safety survey


F Ziemssen, S Grisanti, KU Bartz-Schmidt - British Medical Journal, 2006 - bjo.bmj.com
The observer bias assumed has to be high because there was no standard and
systematic method of measuring the parameters such as blood pressure, 4
intraocular pressure or signs of inflammations. In a questionnaire survey, ...
Cited by 8 - Related articles - All 5 versions

[PDF] BRATS


IDAAPO TRATAMENTO, MRÀI DA … - bvsms.saude.gov.br
A degeneração macular relacionada à idade (DMRI) é uma doença ocular
caracterizada pelo dano à mácula. Quando há lesão na mácula, a região
central das imagens é bloqueada, ocorrendo perda progressiva da visão ...
Related articles - View as HTML - All 10 versions

The ethics of off-label use of drugs: oncology pharmacy in Italy


AB PharmD, RP MD - Journal of Clinical Pharmacy and Therapeutics - interscience.wiley.com
The off-label use of drugs is very common in cancer treatment for many reasons.
This practice is challenging for pharmacists who practice in oncology, for
bureaucratic and medico-legal reasons and for reasons concerning ethics. ...
Related articles

[PDF] JBB


C Bombardier, R Burgos-Vargas, B Davis, R … - N Engl J Med, 2000 - dida.library.ucsf.edu
The New England Journal of Medicine Table 1. Criteria for Gastrointestinal
Events. Event Perforación duc to nonnialignant gastric or duodenal ulcer
Obstruction due to gastric or duodenal ulcer Upper gastrointestinal ...
Cited by 3 - Related articles

Avastin in myopic choroidal neovascularisation: is age the limit?

- prsjournal.com
D Wong, KKW Li - British Journal of Ophthalmology, 2008 - bjo.bmj.com
There are a growing number of publications supporting the use of Avastin
(bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological
myopia (table 1).1 – 8 In this issue, Arias et al (see page 1035) ...
Cited by 1 - Related articles - All 4 versions

[CITATION] The responsability of the ophthalmologist when using drugs which are uneconomic from the …


JA Menendez de Lucas, R Morcillo Laiz - Archivos de la Sociedad Española de Oftalmología, 2007 - SciELO Brasil
Cited by 1 - Related articles - Cached - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google